Variant report
Variant | nsv818817 |
---|---|
Chromosome Location | chr11:49326534-49358347 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:21)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:21 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr11:49332880-49333223 | IMR90 | lung: | n/a | n/a |
2 | CEBPB | chr11:49332869-49333147 | HepG2 | liver: | n/a | n/a |
3 | CTCF | chr11:49340030-49340071 | Pancreas_OC | pancreas: | n/a | n/a |
4 | CTCF | chr11:49339405-49339580 | K562 | blood: | n/a | n/a |
5 | CTCF | chr11:49335020-49335089 | ProgFib | skin: | n/a | n/a |
6 | E2F4 | chr11:49341977-49342137 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | JUN | chr11:49348960-49349482 | HUVEC | blood vessel: | n/a | chr11:49349211-49349219 chr11:49349183-49349192 |
8 | MAFK | chr11:49341949-49342039 | HepG2 | liver: | n/a | n/a |
9 | MAFK | chr11:49357196-49357396 | HepG2 | liver: | n/a | chr11:49357324-49357334 chr11:49357328-49357339 chr11:49357328-49357339 |
10 | MAFK | chr11:49337767-49337955 | HepG2 | liver: | n/a | chr11:49337897-49337908 chr11:49337895-49337909 chr11:49337896-49337912 chr11:49337896-49337907 chr11:49337897-49337908 |
11 | POLR2A | chr11:49353520-49353659 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | POLR2A | chr11:49326609-49326749 | ProgFib | skin: | n/a | n/a |
13 | POLR2A | chr11:49329809-49329887 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | POLR2A | chr11:49336353-49336511 | MCF10A-Er-Src | breast: | n/a | n/a |
15 | POLR2A | chr11:49339879-49339997 | GM12878 | blood: | n/a | n/a |
16 | POLR2A | chr11:49348698-49348754 | HUVEC | blood vessel: | n/a | n/a |
17 | POLR2A | chr11:49341687-49341822 | GM12878 | blood: | n/a | n/a |
18 | POLR2A | chr11:49354248-49354365 | A549 | lung: | n/a | n/a |
19 | POLR2A | chr11:49348466-49348595 | HUVEC | blood vessel: | n/a | n/a |
20 | POLR2A | chr11:49340209-49340334 | GM12878 | blood: | n/a | n/a |
21 | ZKSCAN1 | chr11:49335743-49335756 | Hela-S3 | cervix: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000255532 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs561797078 | chr11:49326620-49326621 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs1164674 | chr11:49326629-49326630 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs547045202 | chr11:49326644-49326645 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs541460922 | chr11:49326665-49326666 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs35460813 | chr11:49326677-49326678 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs570437752 | chr11:49326715-49326716 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs144074728 | chr11:49326741-49326742 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs192711539 | chr11:49326743-49326744 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs1684258 | chr11:49340020-49340021 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs567359229 | chr11:49340064-49340065 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs529102817 | chr11:49340076-49340077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536396136 | chr11:49340160-49340161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs185518049 | chr11:49340184-49340185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs527795229 | chr11:49340218-49340219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs373456527 | chr11:49340229-49340230 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs34492597 | chr11:49340238-49340239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs547766576 | chr11:49340239-49340240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs112070571 | chr11:49340270-49340271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs533669725 | chr11:49340336-49340337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs138800085 | chr11:49340358-49340359 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs190448266 | chr11:49340376-49340377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs61885305 | chr11:49340384-49340385 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs539497727 | chr11:49340387-49340388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs555204682 | chr11:49341400-49341401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs573786809 | chr11:49341411-49341412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs192114985 | chr11:49341485-49341486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs542990651 | chr11:49341508-49341509 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs61885307 | chr11:49341560-49341561 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
29 | rs573109111 | chr11:49341605-49341606 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs541518181 | chr11:49341634-49341635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs183325945 | chr11:49341647-49341648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs559228213 | chr11:49341667-49341668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs186557441 | chr11:49341676-49341677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs189819244 | chr11:49341705-49341706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs138843724 | chr11:49341718-49341719 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs540290168 | chr11:49341798-49341799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs563707848 | chr11:49341802-49341803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs560399343 | chr11:49341806-49341807 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs57087386 | chr11:49341816-49341817 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs549298020 | chr11:49341822-49341823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs559496469 | chr11:49341823-49341824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs528632552 | chr11:49341863-49341864 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs142740574 | chr11:49341930-49341931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs147391057 | chr11:49341937-49341938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs532508407 | chr11:49341951-49341952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs188423935 | chr11:49341953-49341954 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs567294854 | chr11:49341957-49341958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs536535364 | chr11:49341962-49341963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs192896555 | chr11:49342008-49342009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs185121630 | chr11:49342033-49342034 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Wilms tumour | 21544195 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Potocki-Shaffer syndrome | 19222835 | CNVD |
WAGR syndrome | 19222835 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 18632612 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22581003 | CNVD |
Breast cancer | 21990379 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:49340000-49340400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr11:49341400-49342200 | Enhancers | Liver | Liver |
3 | chr11:49347600-49348600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr11:49347600-49348600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
5 | chr11:49347800-49349400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
6 | chr11:49347800-49350400 | Enhancers | HUVEC | blood vessel |
7 | chr11:49348000-49348600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr11:49348000-49349400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
9 | chr11:49348200-49348600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
10 | chr11:49348200-49350200 | Enhancers | Ovary | ovary |
11 | chr11:49348400-49348800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
12 | chr11:49348400-49348800 | Enhancers | Fetal Heart | heart |
13 | chr11:49348800-49349000 | Flanking Active TSS | Fetal Heart | heart |
14 | chr11:49349000-49349200 | Enhancers | Fetal Heart | heart |
15 | chr11:49349200-49349400 | Flanking Active TSS | Fetal Heart | heart |
16 | chr11:49349200-49349800 | Enhancers | Aorta | Aorta |
17 | chr11:49349400-49351600 | Enhancers | Fetal Heart | heart |
18 | chr11:49351600-49353600 | Weak transcription | Fetal Heart | heart |
19 | chr11:49353600-49354200 | Enhancers | Fetal Heart | heart |